{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:47:04Z","timestamp":1774486024571,"version":"3.50.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Hereditary angioedema (HAE) is a rare, life-threatening autosomal dominant genetic disorder caused by a deficient and\/or dysfunctional C1 esterase inhibitor (C1-INH) (type 1 and type 2) leading to recurrent episodes of edema. This study aims to explore HAE patients\u2019 metabolomic profiles and identify novel potential diagnostic biomarkers for HAE. The study also examined distinguishing HAE from idiopathic angioedema (AE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Blood plasma samples from 10 HAE (types 1\/2) patients, 15 patients with idiopathic AE, and 20 healthy controls were collected in Latvia and analyzed using LC-MS based targeted metabolomics workflow. T-test and fold change calculation were used to identify metabolites with significant differences between diseases and control groups. ROC analysis was performed to evaluate metabolite based classification model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 33 metabolites were detected and quantified. The results showed that isovalerylcarnitine, cystine, and hydroxyproline were the most significantly altered metabolites between the disease and control groups. Aspartic acid was identified as a significant metabolite that could differentiate between HAE and idiopathic AE. The mathematical combination of metabolites (hydroxyproline * cystine)\/(creatinine * isovalerylcarnitine) was identified as the diagnosis signature for HAE. Furthermore, glycine\/asparagine ratio could differentiate between HAE and idiopathic AE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study identified isovalerylcarnitine, cystine, and hydroxyproline as potential biomarkers for HAE diagnosis. Identifying new biomarkers may offer enhanced prospects for accurate, timely, and economical diagnosis of HAE, as well as tailored treatment selection for optimal patient care.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1324671","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T12:59:53Z","timestamp":1714049993000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploring disease-specific metabolite signatures in hereditary angioedema patients"],"prefix":"10.3389","volume":"15","author":[{"given":"Adine","family":"Kanepa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingzhi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitrijs","family":"Rots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annija","family":"Vaska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ansone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monta","family":"Briviba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janis","family":"Klovins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalja","family":"Kurjane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristaps","family":"Klavins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.2500\/aap.2020.41.200050","article-title":"Hereditary angioedema: Epidemiology and burden of disease","volume":"41","author":"Lumry","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2020.41.200040","article-title":"Definition and classification of hereditary angioedema","volume":"41","author":"Proper","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2019.40.4267","article-title":"Hereditary and acquired angioedema","volume":"40","author":"Patel","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/all.15214","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema\u2014The 2021 revision and update","volume":"77","author":"Maurer","year":"2022","journal-title":"Allergy: Eur J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08845-6","article-title":"Biomarkers in hereditary angioedema","volume":"60","author":"Porebski","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2020.03099","article-title":"Cut-off value of C1-inhibitor function for the diagnosis of hereditary angioedema due to C1-inhibitor deficiency","volume":"10","author":"Honda","year":"2021","journal-title":"Intractable Rare Dis Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785736","article-title":"Angioedema without wheals: challenges in laboratorial diagnosis","volume":"12","author":"Grumach","year":"2021","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2021.113109","article-title":"The crux of C1-INH testing in everyday lab work","volume":"497","author":"Sch\u00f6ffl","year":"2021","journal-title":"J Immunol Methods"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/ijms21041195","article-title":"Metabolomics to improve the diagnostic efficiency of inborn errors of metabolism","volume":"21","author":"Mordaunt","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.3390\/molecules26113311","article-title":"Advances in the study of metabolomics and metabolites in some species interactions","volume":"26","author":"Liu","year":"2021","journal-title":"Molecules."},{"key":"B11","doi-asserted-by":"publisher","first-page":"100409","DOI":"10.1016\/j.coisb.2021.100409","article-title":"Metabolomics in diagnostics of inborn metabolic disorders","volume":"29","author":"Jans","year":"2022","journal-title":"Curr Opin Syst Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3390\/metabo12111140","article-title":"Altered urinary metabolomics in hereditary angioedema","volume":"12","author":"Wang","year":"2022","journal-title":"Metabolites."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.631688","article-title":"Tandem mass spectrometry screening for inborn errors of metabolism in newborns and high-risk infants in southern China: disease spectrum and genetic characteristics in a chinese population","volume":"12","author":"Tan","year":"2021","journal-title":"Front Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2199710\/v1","article-title":"National survey on clinical and genetic characteristics of patients with hereditary angioedema in Latvia","author":"Kanepa","year":"2023","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.04.035","article-title":"Relationship between the plasma acylcarnitine profile and cardiometabolic risk factors in adults diagnosed with cardiovascular diseases","volume":"507","author":"Kukharenko","year":"2020","journal-title":"Clinica Chimica Acta"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-022-02953-4","article-title":"Specific lysophosphatidylcholine and acylcarnitine related to sarcopenia and its components in older men","volume":"22","author":"Meng","year":"2022","journal-title":"BMC Geriatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5587428","DOI":"10.1155\/2021\/5587428","article-title":"The correlation between gut microbiota and serum metabolomic in elderly patients with chronic heart failure","volume":"2021","author":"Wang","year":"2021","journal-title":"Mediators Inflamm"},{"key":"B18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2174\/1389203717666151201192247","article-title":"Hydroxyproline: A potential biochemical marker and its role in the pathogenesis of different diseases","volume":"17","author":"Srivastava","year":"2016","journal-title":"Curr Protein Pept Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-93","article-title":"Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice","volume":"8","author":"Sch\u00f6nig","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40364-017-0097-4","article-title":"Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives","volume":"5","author":"Kuo","year":"2017","journal-title":"biomark Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2012.00865.x","article-title":"Human serum metabolic profiles are age dependent","volume":"11","author":"Yu","year":"2012","journal-title":"Aging Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1324671\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T12:59:56Z","timestamp":1714049996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1324671\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2024.1324671"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1324671","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"article-number":"1324671"}}